Article Data

  • Views 617
  • Dowloads 111

Original Research

Open Access

Effect of letrozole combined with testosterone on the proliferation and apoptosis of endometrial carcinoma cells

  • Di Wu1
  • Jirui Zhang1
  • Chengxi Yang2,*,

1 Xuzhou Medical University, Lianyungang 222002, P. R. China

2Reproductive Center, Lianyungang Hospital Affiliated to Xuzhou Medical University, Lianyungang 222002, P. R. China

DOI: 10.31083/j.ejgo.2020.04.5208 Vol.41,Issue 4,August 2020 pp.604-608

Submitted: 24 February 2019 Accepted: 03 June 2019

Published: 15 August 2020

*Corresponding Author(s): Chengxi Yang E-mail: dryangchengxi@163.com

Abstract

Objective: To investigate the effect of the androgen testosterone on Ishikawa endometrial cancer (EC) cells in the presence of the aromatase inhibitor letrozole. Methods: Cultured Ishikawa EC cells were divided into three treatment groups: testosterone plus letrozole, testosterone alone and letrozole alone. The respective groups were treated for 48 h with these agents at final concentrations of 0.5, 1, 1.5, 2 or 2.5 µmol/L. The effect of combined letrozole and testosterone treatment was determined by MTT assay and flow cytometry. The effects of combined treatment on cell proliferation and apoptosis were also measured, while the concentration of estrogen in the culture solution was measured after treatment at a concentration of 2.5 µmol/L. Results: Inhibition of proliferation in the testosterone plus letrozole group increased with the concentration of these agents, with maximal inhibition observed at 2.5 µmol/L. Similarly, the rate of apoptosis increased with increasing concentration in the combined testosterone plus letrozole group. The proliferation and apoptosis rates were different between the three different testosterone and letrozole groups, while the estrogen concentration of the testosterone plus letrozole group was significantly lower that of the testosterone group. Conclusion: The androgen testosterone has anti-proliferative and pro-apoptotic effects on EC cells.

Keywords

Endometrial cancer; Androgen; Antitumor; Proliferation; Apoptosis

Cite and Share

Di Wu,Jirui Zhang,Chengxi Yang. Effect of letrozole combined with testosterone on the proliferation and apoptosis of endometrial carcinoma cells. European Journal of Gynaecological Oncology. 2020. 41(4);604-608.

References

[1] Labrie F.: “All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause”. J. Steriod. Biochem. Mol. Biol., 2015, 145, 133.

[2] Gini Fleming F.: “Second­Line Therapy for Endometrial Cancer: The Need for Better Options. J. Clin. Oncol., 2015, 33, 3535.

[3] Allen N.E., Key T.J., Dossus L., et al.: “Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC)[J]”. Endocr. Relat. Cancer, 2008, 15, 485.

[4] Gotlieb W.H., Beiner M.E., Shalmon B., Korach Y., Segal Y., Zmira N., et al. “Outcome of fertility­sparing treatment with progestins in young patients with endometrial cancer”. Obstetr. Gynecol., 2003, 102, 718.

[5] Audet­Walsh E., Lépine J., Grégoire J., Plante M., Caron P., Tétu B., et al.: “Profiling of endogenous estrogens, their precursors, and metabolites in endometrial cancer patients: association with risk and relationship to clinical characteristics”. J. Clin. Endocrinol. Metabol., 2011, 96, 330.

[6] Emons G., Heyl W.: “Hormonal treatment of endometrial cancer”. J Cancer Res Clin Oncol., 2000, 126, 619.

[7] Davis S.R.: “Cardiovascular and cancer safety of testosterone in women”. Curr. Opin. Endocrinol. Diabetes Obes., 2011, 18, 198.

[8] Dossus L., Lukanova A., Rinaldi S., Allen N., Cust A.E., Becker S., et al.: “Hormonal, Metabolic, and Inflammatory Profiles and Endometrial Cancer Risk Within the EPIC Cohort—A Factor Anal­ ysis”. Am. J. Epidemiol., 2013, 177, 787.

[9] Piltonen T.T.: “Polycystic ovary syndrome: Endometrial markers”. Best Pract. Res. Clin. Obstet. Gynaecol., 2016, 37, 1.

[10] Davis S.R., Wahlin­Jacobsen S.: “Testosterone in women—the clin­ ical significance”. Lancet Diabetes Endocrinol.,2015, 3, 980.

[11] Clendenen T.V., Hertzmark K., Koenig K.L., Lundin E., Rinaldi S., Johnson T., et al: “Premenopausal Circulating Androgens and Risk of Endometrial Cancer: results of a Prospective Study”. Horm. Can­ cer, 2016, 7, 178.

[12] Zhao P.L., Zhang Q.F., Yan L.Y., Huang S., Chen Y., Jie Q., et al.: “Functional investigation on aromatase in endometrial hyperplasia in polycystic ovary syndrome cases”. Asian. Pac. J. Cancer Prev., 2014, 15, 8975.

[13] Li L., Feng W.: “Changes and significance of serum testosterone levels in patients with endometrial cancer”. Shandong Med. J., 2015, 68.

[14] Lanzino M., Sisci D., Morelli C., Garofalo C., Sebastiano A.: “In­ hibitor of cyclin D1 expression by androgen receptor in breast cancer cells­identification of a novel androgen response element”. Nucleic Acids Res., 2010,38, 5351.

[15] Saito S., Ito K., Suzuki T., Utsunomiya H., Akahira J.I., Sugihashi Y., et al.: “Orphan nuclear receptor DAX­1 in human endometrium asnd its disorders”. Cancer Science, 2005, 96, 645.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top